title: Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).
abstract: Invasive fungal infections (IFIs) caused by filamentous fungi still have high rates of mortality, associated with difficulties in early detection of the infection and therapeutic limitations. Consequently, a useful approach is to prevent patients at risk of fungal infection from coming into contact with conidia of Aspergillus and other mould species. This document describes the recommendations for preventing IFI caused by filamentous fungi worked out by Spanish experts from different medical and professional fields. The article reviews the incidence of IFI in different risk populations, and questions related to environmental measures for prevention, control of hospital infections, additional procedures for prevention, prevention of IFI outside of hospital facilities and antifungal prophylaxis are also analysed.
authors.affiliation: Infectious Diseases Department, Hospital de Vall d'Hebron, Barcelona, Spain.
authors.forename: I
authors.initials: I
authors.lastname: Ruiz-Camps
authors.forename: J M
authors.initials: JM
authors.lastname: Aguado
authors.forename: B
authors.initials: B
authors.lastname: Almirante
authors.forename: E
authors.initials: E
authors.lastname: Bouza
authors.forename: C F
authors.initials: CF
authors.lastname: Ferrer-Barbera
authors.forename: O
authors.initials: O
authors.lastname: Len
authors.forename: L
authors.initials: L
authors.lastname: Lopez-Cerero
authors.forename: J L
authors.initials: JL
authors.lastname: Rodríguez-Tudela
authors.forename: M
authors.initials: M
authors.lastname: Ruiz
authors.forename: A
authors.initials: A
authors.lastname: Solé
authors.forename: C
authors.initials: C
authors.lastname: Vallejo
authors.forename: L
authors.initials: L
authors.lastname: Vazquez
authors.forename: R
authors.initials: R
authors.lastname: Zaragoza
authors.forename: M
authors.initials: M
authors.lastname: Cuenca-Estrella
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use; D018890:Chemoprevention / Q000379:methods; D017714:Community-Acquired Infections / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control; D003428:Cross Infection / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control*; D005658:Fungi / Q000302:isolation & purification*; D006801:Humans; D015994:Incidence; D017053:Infection Control / Q000379:methods*; D009181:Mycoses / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control*; D013030:Spain / Q000453:epidemiology
chemical_list: D000935:Antifungal Agents